Table 1.
Total bimax | TIVA | InhA-R | InhA | P |
---|---|---|---|---|
(269) | (30) | (233) | (6) | |
Sex | 0.305 | |||
Male | 14 (46.7%) | 133 (57.1%) | 2 (33.3%) | |
Female | 16 (53.3%) | 100 (42.9%) | 4 (66.7%) | |
Age (yr) | 23.0±4.2 | 23.7±5.1 | 23.8±4.9 | 0.777 |
Weight (kg) | 58.6±10.9 | 63.4±11.8 | 64.8±5.5 | 0.209 |
BMI | 21.6±2.8 | 21.9±3.4 | 23.8±2.9 | 0.309 |
ASA | 0.819 | |||
I | 24 (80.0%) | 166 (71.2%) | 5 (83.3%) | |
II | 6 (20.0%) | 65 (27.9%) | 1 (16.7%) | |
III | 0 | 2 (0.9%) | 0 | |
Dose of TCI (Cet) propofol (µg/mL) | 3.0±0.4 | NA | NA | NA |
Inhalational agent | ||||
Desflurane | NA | 232 (99.6%) | 4 (66.7%) | <0.001 |
Dose | 6.2±0.8 | 6.9±0.2 | 0.088 | |
Sevoflurane | NA | 1 (0.4%) | 2 (33.3%) | <0.001 |
Dose | 1.9 | 2.1 | NA | |
EBL (mL) | 977.0±493.7 | 978.4±495.6 | 933.3±242.2 | 0.976 |
Transfusion requirement | 22 (73.3%) | 143 (61.4%) | 4 (66.7%) | 0.435 |
Length of hospital stay (h) | 62.6±12.7 | 62.1±15.8 | 58.5±13.3 | 0.841 |
* TIVA - total intravenous anaesthesia, VA - inhalational anaesthesia, BMI - body mass index, ASA - American Society of Anesthesiologists (ASA) physical status classification system, SBP - systolic blood pressure, DBP - diastolic blood pressure, TCI (Cet) - target controlled infusion (target effect site concentration), EBL - estimated blood loss, Bimax - bimaxillary surgery, InhA-R - inhalational anaesthesia with remifentanil, InhA - inhalational anaesthesia without remifentanil. Data presented as mean±standard deviation (SD) or number (proportion). P<0.05 means statistically significant